Towards new combination therapies for the treatment of chronic lymphocytic leukemia

At the 20th Congress of the European Hematology Association (EHA), Paolo Ghia, MD, PhD, of Università Vita-Salute San Raffaele, Milan, Italy, discusses the development of new and more effective therapies, which are focusing on anti-CD20 monoclonal antibody-containing regimens, for the treatment of patients with chronic lymphocytic leukemia.

Share this video  
12th June 2015